Treatment of Moderate-to-Severe Glabellar Lines With RelabotulinumtoxinA, an Investigational Liquid Botulinum Toxin: Clinical Efficacy and Safety Results From the READY-1 Phase 3 Trial
Solish, Nowell, Moradi, Amir, Shridharani, Sachin, Donofrio, Lisa, Gold, Michael H, Biesman, Brian, Chiang, Melissa, George, Rosalyn, Polder, Kristel, Schwarcz, Rob, Lin, Xiaoming, Coquis-Knezek, Sarah
Published in Toxicon (Oxford) (01.01.2024)
Published in Toxicon (Oxford) (01.01.2024)
Get full text
Journal Article